What is the best treatment for chronic constipation in the elderly? by Kalish, Virginia B. & Loven, Bridget
1050	 vol 56, No 12 / December 2007  The Journal of family PracTice
CliniCal INquIrIes From the Family Physicians 
Inquiries Network
		
What	is	the	best	treatment		
for	chronic	constipation		
in	the	elderly?
Virginia B. Kalish, MD
Dewitt Army Community  
Hospital-National Capital  
Consortium Residency Program, 
Fort Belvoir, Va
Bridget loven MliS
Carolinas Healthcare System, 
Charlotte, NC
There is no one best evidence-based 
treatment for chronic constipation in the 
elderly. While the most common first-line 
treatments are dietary fiber and exercise, 
the evidence is insufficient to support 
this approach in the geriatric population 
(strength of recommendation [sor]: for 
dietary fiber: a, based on a systematic 
review; for exercise: sor: B, based on 
1 good- and 1 fair-quality randomized 
controlled trial [rcT]). 
 Herbal supplements (such as aloe), 
alternative treatments (biofeedback), 
lubricants (mineral oil), and combination 
laxatives sold in the us have not been 
sufficiently studied in controlled trials to 
make a recommendation (sor: a, based 
on systematic review). 
 An abdominal kneading device can be 
used to treat chronic constipation, but the 
evidence is limited (sor: B, based on 1 
cohort study.)
 Polyethylene glycol has not been 
studied in the elderly. A newer agent, 
lubiprostone (Amitiza), appears to be 
effective for the treatment of chronic 
constipation for elderly patients (sor: B, 
based on subgroup analysis of rcTs.) 
is the patient truly constipated?
many older people feel that if they do not 
have a bowel movement every day they 
are constipated. However, constipation is 
defined as fewer than 3 bowel movements 
per week. so, the first thing we must do is to 
confirm that the patient is truly constipated.
 before I start my patients on any 
medicine, I suggest a trial of increased daily 
water and fiber intake along with exercise, 
followed by a trial of stool softeners and 
stimulant laxatives, if needed. If all of these 
methods fail, I consider trying polyethylene 
glycol, which can be titrated to effect. As 
with all medication use by the elderly, it is 
important to titrate cautiously (“start low 
and go slow”) and add other medications 
only when necessary.   
Mandi Sehgal, MD
Department of Family medicine/Geriatrics, 
university of cincinnati
clinical commentary
evidence-based answer
fast track
Inconsistent  
research findings 
cast doubt on the 
efficacy of fiber 
treatment  
for constipation
z	Evidence	summary
Few well-designed studies have focused 
on constipation treatment among the 
elderly. Our search located 1 systematic 
review of pharmacologic management, a 
systematic review of fiber management, 
2 RCTs on the effect of exercise, and 
1 before-after cohort study on abdominal 
massage. These studies were all conducted 
among geriatric patients with constipa-
tion. Two high-quality systematic reviews 
regarding chronic constipation manage-
fast track
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ment for adults of all ages included man-
agement options not studied in exclu-
sively geriatric populations, such as herbal 
supplements, biofeedback, tegaserod, and 
polyethylene glycol.
Laxatives,	fiber,	and	exercise:		
Studies	are	inconclusive
Two good-quality systematic reviews 
looked at 10 RCTs comparing laxatives 
with placebo, and 10 RCTs comparing 
1 laxative with another.1,2 The studies 
generally had few participants, were of 
short duration, and were conducted in 
institutional settings. Most lacked power 
to make valid conclusions. These studies 
varied in the reported outcome measures, 
including stool frequency, stool con-
sistency, straining, decrease in laxative 
use, and symptom scores. The reviews 
concluded that the best pharmacologic 
treatment for chronic constipation in the 
elderly has not been established. 
Five of the higher-quality studies 
attained statistical significance. They 
showed a small but significant improve-
ment in bowel movement frequency with 
a laxative when compared with placebo 
or another laxative (TabLE). The authors 
noted that multiple poor-quality stud-
ies have shown nonsignificant trends for 
improved constipation symptoms with 
laxatives compared with placebo. 
inconsistent findings on fiber. A good-
quality systematic review3 of dietary fiber 
in the treatment of constipation for older 
patients located 8 moderate- to high-
quality studies (6 RCTs and 2 blinded 
before-after studies), with 269 study par-
ticipants in institutional settings. Results 
among studies were inconsistent, casting 
doubt on the efficacy of fiber treatment 
for constipation in the institutionalized 
elder. 
Two RCTs4,5 investigating the effect 
of exercise on 246 institutionalized older 
patients showed no improvement in con-
stipation. One study was of good qual-
ity, reporting adequate power and used 
an intention-to-treat analysis. The other 
was of fair quality.
alternative	TXs	not	well	studied
A high-quality systematic review6 of con-
stipation management among adults of 
all ages in North America found a lack of 
quality RCTs examining herbal supple-
ment treatment. Biofeedback has been 
studied in adult populations, but no RCTs 
with placebo or sham-controls have been 
published. 
One before-after cohort study7 inves-
tigated an external kneading mechanical 
device (Free-Lax) that was applied to the 
abdomen for 20 minutes once daily in 30 
randomly selected chronically constipated 
nursing home residents. Researchers found 
significant improvements in bowel move-
ment frequency, stool consistency and vol-
ume, and colonic transit time without side 
effects (TabLE). 
a	look	beyond	geriatric	patients	
Polyethylene glycol, tegaserod, and lu-
biprostone have not been studied in tri-
als of exclusively geriatric populations. 
Two high-quality systematic reviews,6,8 
including medium- to high-quality RCTs 
of pharmacologic management of chron-
ic constipation, found good evidence to 
support treatment with polyethylene gly-
col and tegaserod in adults of all ages. 
Of the 8 RCTs looking at polyethylene 
glycol, only 1 of the studies—a high- 
How	well	do	these	interventions	work		
for	older	patients	with	chronic	constipation?
inTervenTion  STool frequency 
vS comPariSon (SToolS Per week) nnT‡
agiolax* vs lactulose 4.5 vs 2.2 43
agiolax* vs lactulose 5.6 vs 4.2 71
lactitol† vs  placebo 4.9 vs 3.6 77
lactitol† vs lactulose 5.5 vs 4.9 160
lactulose vs sorbitol† 7.0 vs 6.7 330
external abdominal  3.9 vs 1.4 40 
kneading (before-after)
*  Agiolax is a combination bulk and stimulant laxative not readily found in the  
united states.
†  lactitol and sorbitol are sugar alcohols used as replacement sweeteners and  
approved by the FDA as food additives.
‡ Number needed to treat (NNT) for 1 person to have 1 more stool per week. 
taBle 
2 RCTs showed no 
improvement of 
constipation from 
exercise in older 
patients
fast track
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quality crossover comparison of poly-
ethylene glycol vs placebo with 37 out-
patient subjects—included a population 
with a mean age >60 years (mean age 62, 
range 42–89 years). 
A subgroup analysis9 of 331 elderly 
patients enrolled in 2 RCTs of tegaserod 
found no difference in outcomes between 
treatment with tegaserod and placebo, al-
though this analysis was limited by inad-
equate power. 
Tegaserod linked to ischemic events. 
A recent analysis of clinical trials found a 
statistically significant increase in cardio-
vascular ischemic events associated with 
tegaserod. The manufacturer took the 
product off the market in compliance with 
an FDA request in March 2007. 
lubiprostone offers promise. Lubipro-
stone, a chloride channel activator ap-
proved by the FDA for the treatment of 
chronic idiopathic constipation, has been 
studied in 6 placebo-controlled, double-
blind, randomized Phase II and III clinical 
trials. In 2 unpublished pooled analyses of 
3 of the trials, lubiprostone was found to 
be effective in a total of 220 elderly pa-
tients 65 years of age and older.10,11 
Recommendations	from	others
The American College of Gastroenterology 
Chronic Constipation Task Force evi-
dence-based guidelines make no refer-
ence to age, but state that evidence is best 
for treatment with psyllium, tegaserod, 
polyethylene glycol, and lactulose.12 They 
found insufficient evidence to support  use 
of stimulants, stool softeners, lubricants, 
herbal supplements, biofeedback, and al-
ternative treatments. 
The American Gastroenterological 
Association guidelines on constipation are 
primarily based on expert opinion.13 Age 
is not specified in their recommendations. 
Dietary and exercise modifications are 
recommended as first-line treatments, fol-
lowed by laxatives. Laxatives are recom-
mended based on cost, in order from the 
least to most expensive agents. Supposito-
ries, enemas, biofeedback, and (in refrac-
tory cases) surgery are recommended for 
patients with pelvic floor dysfunction. 
The Registered Nurses Association of 
Ontario guidelines for constipation pre-
vention in the older adult population rec-
ommend fluid and dietary fiber, regular 
exercise, and consistent toileting.14   n 
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to support the use 
of polyethylene 
glycol in adults  
of all ages
